Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18236117.
- Also identified by DOI 10.1245/s10434-007-9705-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Conventional cytotoxic chemotherapy has not provided clinical benefit or prolonged survival for patients with advanced HCC. This review summarizes the results of prospective clinical trials of several categories of systemic therapy, with emphasis on the more promising results from recent trials of biologically targeted therapeutic agents in HCC.
Medical subject headings
- Antineoplastic Agents
- Carcinoma, Hepatocellular
- Liver Neoplasms